Product Reports Resources Pricing Login Book a demo

Carlsmed

Biotech & Life Sciences · United States · Founded 2018 · IPO 2025

Carlsmed is personalized surgical implants for patients with debilitating spine deformities MoreLess

Carlsmed operates in the medical technology sector, focusing on personalized spine surgery solutions. The company leverages patient data and advanced digital technologies to create customized surgical plans and 3D-printed spine fusion devices, known as aprevo implants. These implants are tailored to each patient's unique anatomical needs, ensuring optimal surgical outcomes. Carlsmed serves healthcare professionals, particularly spine surgeons, and their patients who require spine fusion surgeries. The business model revolves around the integration of patient imaging data, surgeon preferences, and digital design to produce bespoke surgical solutions. Revenue is generated through the sale of these personalized implants and associated surgical planning services. By providing highly customized medical devices, Carlsmed aims to improve surgical precision and patient recovery times.

Keywords: personalized spine surgery, 3D-printed implants, patient-specific plans, digital technologies, spine fusion devices, healthcare professionals, surgical precision, medical technology, patient data, bespoke surgical solutions.

Valuation $262M
Revenue $75M
Total funding $50–100M

Talent graph

Carlsmed's talent

Book a demo to see the people
Employees mapped 148 incl. 1 AI specialist
Founders Hidden — book a demo/100 quality score
Key operators 9 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Carlsmed's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 2 investors entered at this stage
The Cove Fund
Wavemaker Three-Sixty Health
Series A 3 investors entered at this stage
Series B+ 1 investor entered at this stage
Customers Bank

Global footprint

Where Carlsmed has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
6.9K monthly visits
across markets
🇺🇸 United States85.5%
🇮🇳 India14.5%
Top 2 markets shown

Market sentiment

What the market is saying about Carlsmed

An AI-synthesized read of the highest-engagement posts about Carlsmed on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Carlsmed on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.